• Kyodo

  • SHARE

Keio University is poised to conduct the world’s first treatment of patients who have sustained spinal cord injuries using induced pluripotent stem cells, sources close to the matter said Tuesday.

If approved by the state, the private university plans to inject neural stem cells produced from iPS cells into four people aged 18 or older who were injured while playing sports or in traffic accidents, starting next year.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)